Meitav Dash Investments LTD Keros Therapeutics, Inc. Transaction History

Meitav Dash Investments LTD

  • $4.92 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$37.26 - $51.01 $59,504 - $81,462
1,597 New
1,597 $64,000
Q2 2022

Aug 01, 2022
SELL
$26.03 - $67.04 $2.49 Million - $6.41 Million
-95,644 Reduced 84.55%
17,475 $482,000
Q1 2022

May 09, 2022
SELL
$42.12 - $59.36 $1.03 Million - $1.46 Million
-24,517 Reduced 17.81%
113,119 $6.15 Million
Q3 2021

Nov 03, 2021
BUY
$29.27 - $43.71 $4.03 Million - $6.02 Million
137,636 New
137,636 $5.45 Million

Others Institutions Holding KROS

# of Institutions
153
Shares Held
26.7M
Call Options Held
47.6K
Put Options Held
34.5K
View Full List

About Keros Therapeutics, Inc.

KROS Quotes by TradingView
  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $1.18B
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Meitav Dash Investments LTD Portfolio

Follow Meitav Dash Investments LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Meitav Dash Investments LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email